(5E)-1-(2-methoxyphenyl)-5-[(2E)-3-phenylprop-2-en-1-ylidene]pyrimidine-2,4,6(1H,3H,5H)-trione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: (5E)-1-(2-methoxyphenyl)-5-[(2E)-3-phenylprop-2-en-1-ylidene]pyrimidine-2,4,6(1H,3H,5H)-trione
• 英文别名: (5E)-1-(2-methoxyphenyl)-5-[(E)-3-phenylprop-2-enylidene]-1,3-diazinane-2,4,6-trione
• 化学式: C₂₀H₁₆N₂O₄
• 分子量: 348.4
• InChiKey: QPXDYLZDZWFMHL-UNRYZTPYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  75.7
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Ubiquitin ligase inhibitors and methods related thereto
  申请人：Alroy Iris

  公开号：US20070015768A1

  公开（公告）日：2007-01-18

  The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
• Method of Treating Kcnq Related Disorders Using Organozinc Compounds
  申请人：Li Min

  公开号：US20110257146A1

  公开（公告）日：2011-10-20

  The instant invention describes methods of treating KCNQ related diseases and disorders using organozinc compounds. In certain embodiments, pain is treated using Zinc Pyrithione.
• Psyllid Attractants and Their Uses
  申请人：INSCENT, INC.

  公开号：US20130287727A1

  公开（公告）日：2013-10-31

  The present specification discloses psyllid attractants, compositions comprising such attractants, lures, traps and other devices using such attractants, methods and uses to attract, capture and/or kill psyllids using such attractants, compositions and/or lures, traps and/or other devices, and methods and uses for monitoring a psyllid population using such attractants, compositions and/or lures, traps and/or other devices.
• US7659277B2
  申请人：——

  公开号：US7659277B2

  公开（公告）日：2010-02-09
• [EN] METHOD OF TREATING KCNQ RELATED DISORDERS USING ORGANOZINC COMPOUNDS<br/>[FR] PROCEDE DESTINE A TRAITER DES TROUBLES LIES A KCNQ A L'AIDE DE COMPOSES ORGANOZINC
  申请人：UNIV JOHNS HOPKINS

  公开号：WO2007087424A2

  公开（公告）日：2007-08-02

  [EN] The instant invention describes methods of treating KCNQ related diseases and disorders using organozinc compounds. In certain embodiments, pain is treated using Zinc Pyrithione.
  [FR] La présente invention concerne des procédés destinés à traiter des pathologies et des troubles liés à KCNQ à l'aide de composés organozinc. Dans certains modes de réalisation, la douleur est traitée à l'aide de pyrithione de zinc.